Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Stephenson, CME; Bigliani, V; Jones, HM; Mulligan, RS; Acton, PD; Visvikis, D; Ell, PJ; Kerwin, RW; Pilowsky, LS
   Striatal and extra-striatal D-2/D-3 dopamine receptor occupancy by quetiapine in vivo - [I-123]-epidepride single photon emission tomography (SPET) study
   BRITISH JOURNAL OF PSYCHIATRY
   
   C.M.E. Stephenson et al., "Striatal and extra-striatal D-2/D-3 dopamine receptor occupancy by quetiapine in vivo - [I-123]-epidepride single photon emission tomography (SPET) study", BR J PSYCHI, 177, 2000, pp. 408-415
2. Bigliani, V; Mulligan, RS; Acton, PD; Ohlsen, RI; Pike, VW; Ell, PJ; Gacinovic, S; Kerwin, RW; Pilowsky, LS
   Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [I-123]epidepride single photon emission tomography (SPET) study
   PSYCHOPHARMACOLOGY
   
   V. Bigliani et al., "Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [I-123]epidepride single photon emission tomography (SPET) study", PSYCHOPHAR, 150(2), 2000, pp. 132-140
3. Bigliani, V; Mulligan, RS; Acton, PD; Visvikis, D; Ell, PJ; Stephenson, C; Kerwin, RW; Pilowsky, LS
   In vivo occupancy of striatal and temporal cortical D-2/D-3 dopamine receptors by typical antipsychotic drugs - [I-123]-epidepride single photon emission tomography (SPET) study
   BRITISH JOURNAL OF PSYCHIATRY
   
   V. Bigliani et al., "In vivo occupancy of striatal and temporal cortical D-2/D-3 dopamine receptors by typical antipsychotic drugs - [I-123]-epidepride single photon emission tomography (SPET) study", BR J PSYCHI, 175, 1999, pp. 231-238
4. BIGLIANI V; MULLIGAN RS; ACTON PD; GACINOVIC S; ELL PJ; KERWIN RW; PILOWSKY LS
   DIFFERENT PATTERNS OF D-2 D-2-LIKE RECEPTOR BLOCKADE IN THE TEMPORAL CORTEX AND THE STRIATUM BY TYPICAL ANTIPSYCHOTICS - AN I-123 EPIDEPRIDE SPET STUDY/
   Schizophrenia research
   
   V. Bigliani et al., "DIFFERENT PATTERNS OF D-2 D-2-LIKE RECEPTOR BLOCKADE IN THE TEMPORAL CORTEX AND THE STRIATUM BY TYPICAL ANTIPSYCHOTICS - AN I-123 EPIDEPRIDE SPET STUDY/", Schizophrenia research, 29(1-2), 1998, pp. 165-165
5. BIGLIANI V; MULLIGAN RS; ACTON PD; STEPHENSON C; GACINOVIC S; ELL PJ; KERWIN RW; PILOWSKY LS
   PRELIMINARY-RESULTS - D-2 D-2-LIKE RECEPTOR-BINDING IN TEMPORAL CORTEX AND STRIATUM IN SERTINDOLE AND OLANZAPINE TREATED PATIENTS/
   The Journal of nuclear medicine
   
   V. Bigliani et al., "PRELIMINARY-RESULTS - D-2 D-2-LIKE RECEPTOR-BINDING IN TEMPORAL CORTEX AND STRIATUM IN SERTINDOLE AND OLANZAPINE TREATED PATIENTS/", The Journal of nuclear medicine, 39(5), 1998, pp. 319-319
6. TRAVIS MJ; BUSATTO GF; PILOWSKY LS; MULLIGAN RS; GACINOVIC S; ACTON PD; COSTA DC; ELL PJ; KERWIN RW
   BROAD-SPECTRUM TYPICAL ANTIPSYCHOTICS AND IN-VIVO 5-HT2A RECEPTOR OCCUPANCY IN SCHIZOPHRENIC-PATIENTS - SPET FINDINGS
   The Journal of nuclear medicine
   
   M.J. Travis et al., "BROAD-SPECTRUM TYPICAL ANTIPSYCHOTICS AND IN-VIVO 5-HT2A RECEPTOR OCCUPANCY IN SCHIZOPHRENIC-PATIENTS - SPET FINDINGS", The Journal of nuclear medicine, 39(5), 1998, pp. 320-320
7. PILOWSKY LS; MULLIGAN RS; ACTON PD; GACINOVIC S; BUSATTO GF; KESSLER RM; ELL PJ; TRAVIS MJ; BIGLIANI V; STEPHENSON C; COSTA DC; KERWIN RW
   PRELIMINARY-REPORT - EFFECTS OF CLOZAPINE AND TYPICAL ANTIPSYCHOTICS ON STRIATAL AND LIMBIC DOPAMINE D2 D2-LIKE RECEPTORS IN-VIVO BY 123I EPIDEPRIDE SPET/
   Schizophrenia research
   
   L.S. Pilowsky et al., "PRELIMINARY-REPORT - EFFECTS OF CLOZAPINE AND TYPICAL ANTIPSYCHOTICS ON STRIATAL AND LIMBIC DOPAMINE D2 D2-LIKE RECEPTORS IN-VIVO BY 123I EPIDEPRIDE SPET/", Schizophrenia research, 24(1-2), 1997, pp. 181-181
8. PILOWSKY LS; MULLIGAN RS; ACTON PD; GACINOVIC S; BUSATTO GF; KESSLER RM; ELL PJ; TRAVIS MJ; BIGLIANI V; STEPHENSON C; COSTA DC; KERWIN RW
   CLOZAPINE SHOWS SELECTIVE OCCUPANCY OF EXTRA-STRIATAL DOPAMINE D2 D2-LIKE RECEPTORS - A 1231-EPIDEPRIDE SPET STUDY - PRELIMINARY FINDINGS
   The Journal of nuclear medicine
   
   L.S. Pilowsky et al., "CLOZAPINE SHOWS SELECTIVE OCCUPANCY OF EXTRA-STRIATAL DOPAMINE D2 D2-LIKE RECEPTORS - A 1231-EPIDEPRIDE SPET STUDY - PRELIMINARY FINDINGS", The Journal of nuclear medicine, 38(5), 1997, pp. 350-350
9. PILOWSKY LS; MULLIGAN RS; ACTON PD; ELL PJ; COSTA DC; KERWIN RW
   LIMBIC SELECTIVITY OF CLOZAPINE
   Lancet
   
   L.S. Pilowsky et al., "LIMBIC SELECTIVITY OF CLOZAPINE", Lancet, 350(9076), 1997, pp. 490-491
10. MULLIGAN RS; LIVESEY JH; EVANS MJ; ELLIS MJ; DONALD RA
    ATRIAL-NATRIURETIC-PEPTIDE AND C-TYPE NATRIURETIC PEPTIDE DO NOT ACUTELY INHIBIT THE RELEASE OF ADRENOCORTICOTROPIN FROM EQUINE PITUITARY-CELLS IN-VITRO
    Neuroendocrinology
    
    R.S. Mulligan et al., "ATRIAL-NATRIURETIC-PEPTIDE AND C-TYPE NATRIURETIC PEPTIDE DO NOT ACUTELY INHIBIT THE RELEASE OF ADRENOCORTICOTROPIN FROM EQUINE PITUITARY-CELLS IN-VITRO", Neuroendocrinology, 65(1), 1997, pp. 64-69
11. EVANS MJ; MULLIGAN RS; LIVESEY JH; DONALD RA
    THE INTEGRATIVE CONTROL OF ADRENOCORTICOTROPIN SECRETION - A CRITICALROLE FOR CORTICOTROPIN-RELEASING HORMONE
    Journal of Endocrinology
    
    M.J. Evans et al., "THE INTEGRATIVE CONTROL OF ADRENOCORTICOTROPIN SECRETION - A CRITICALROLE FOR CORTICOTROPIN-RELEASING HORMONE", Journal of Endocrinology, 148(3), 1996, pp. 475-483
12. ELLIS MJ; MULLIGAN RS; EVANS MJ; DONALD RA
    THE EFFECTS OF CORTICOTROPIN-RELEASING HORMONE, ARGININE-VASOPRESSIN AND THEIR ANTAGONISTS ON ACTH RELEASE FROM PERIFUSED HORSE ANTERIOR-PITUITARY-CELLS
    Journal of Endocrinology
    
    M.J. Ellis et al., "THE EFFECTS OF CORTICOTROPIN-RELEASING HORMONE, ARGININE-VASOPRESSIN AND THEIR ANTAGONISTS ON ACTH RELEASE FROM PERIFUSED HORSE ANTERIOR-PITUITARY-CELLS", Journal of Endocrinology, 143(1), 1994, pp. 85-93